The present invention provides binding agents comprising peptides capable of binding myostatin and inhibiting its activity. In one embodiment the binding agent comprises at least one myostatin-binding peptide attached …
The present application describes methods, compounds, pharmaceutical compositions and kits for treating or preventing amyloid-related diseases. For instance, the application relates to compounds and compositions for …